Portfolio

Pixium Vision awarded Galien Prize 2018 for research with PRIMA system

By 13/12/2018June 4th, 2021No Comments

Pixium Vision (FR0011950641 – PIX), a bioelectronics company developing innovative bionic vision systems to enable patients who have lost their sight to lead more independent lives, announces today that it has been awarded the¬†Prix¬†Galien 2018 in the “Research Project” category¬†for its PRIMA device for the treatment of dry¬†Age-related Macular Degeneration¬†(AMD).

The Galien Foundation attributes this award to Pixium Vision in recognition of the innovative technology of its PRIMA wireless sub-retinal implant, a “brain-machine” interface applied to the eye to create bionic vision in the treatment of persons with dry AMD. The PRIMA device was chosen from a selection of premier projects supported by prestigious academic institutions.

Khalid Ishaque, CEO of Pixium Vision, comments: “It is with pleasure that our entire team of scientific, engineering and medical researchers receives this prestigious award. The Galien Award attests to the very innovative nature of our PRIMA technology owing to elicit visual perception for patients with dry AMD. We are extremely honoured that the Galien Foundation recognizes PRIMA’s major technological and medical advances, which offer new possibilities in the field of bionic vision for the treatment of retinal diseases. We would like to thank the first patients in our¬†clinical trial¬†for their contribution in this breakthrough human endeavour, which will enable us to continue pursuit of our mission.”

“We are proud to accompany Pixium Vision in developing its breakthrough technology, today awarded the Galien Prize. We congratulate the whole team for this highly valuable scientific recognition.”

Created as a “pharmaceutical research award” in France in 1970, the prestigious Prix Galien is recognised by the French authorities for its public interest and has an international reputation. Each year, the Prix Galien recognises the best healthcare innovations in five categories: pharmaceutical products, medical systems, e-health, patient care and research. The Prix Galien is awarded by a jury comprised of 50 international experts in healthcare. Their independence, authority and reputation confirm the excellence and credibility of the Galien Prize.